Santen Pharmaceutical Co., Ltd. (SNPHF)

Santen Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 10, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	3,360	3,232	3,697	3,192	4,043	5,505
Market Cap Growth	-23.63%	-12.57%	15.82%	-21.04%	-26.56%	-20.18%
Enterprise Value	2,795	2,707	3,150	2,727	3,479	5,022
Last Close Price	11.45	10.41	9.24	8.48	11.23	13.70
PE Ratio	15.39	13.35	21.00	-	18.04	89.19
PS Ratio	1.65	1.61	1.85	1.52	1.84	2.44
PB Ratio	1.73	1.70	1.83	1.45	1.46	1.98
P/TBV Ratio	2.34	2.30	2.52	2.15	2.37	3.13
P/FCF Ratio	9.98	8.92	8.83	21.36	17.11	17.56
P/OCF Ratio	8.58	7.95	7.70	11.42	10.66	15.69
EV/Sales Ratio	1.44	1.35	1.58	1.30	1.59	2.23
EV/EBITDA Ratio	6.98	6.12	6.77	6.90	7.98	7.90
EV/EBIT Ratio	9.85	8.39	9.13	10.27	11.78	10.38
EV/FCF Ratio	8.30	7.47	7.52	18.24	14.72	16.02
Debt / Equity Ratio	-	0.12	0.11	0.12	0.10	0.03
Debt / EBITDA Ratio	-	0.52	0.49	0.69	0.62	0.14
Debt / FCF Ratio	-	0.63	0.55	1.82	1.15	0.29
Asset Turnover	0.70	0.71	0.71	0.63	0.62	0.62
Inventory Turnover	2.33	2.72	2.99	2.95	2.79	2.56
Quick Ratio	1.76	1.90	2.00	1.85	1.91	2.02
Current Ratio	2.56	2.58	2.55	2.38	2.39	2.63
Return on Equity (ROE)	10.62%	12.14%	8.92%	-4.75%	8.45%	2.18%
Return on Assets (ROA)	6.34%	7.14%	7.61%	5.01%	5.20%	8.25%
Return on Capital (ROIC)	9.11%	9.16%	9.74%	6.31%	6.53%	10.58%
Return on Capital Employed (ROCE)	13.60%	15.00%	15.20%	10.60%	9.90%	16.50%
Earnings Yield	6.50%	7.49%	4.76%	-3.52%	5.54%	1.12%
FCF Yield	10.02%	11.21%	11.33%	4.68%	5.85%	5.70%
Dividend Yield	2.22%	2.31%	2.36%	2.84%	2.35%	1.85%
Payout Ratio	39.43%	33.40%	44.59%	-	44.07%	163.81%
Buyback Yield / Dilution	3.10%	5.01%	4.98%	3.26%	-0.02%	-0.03%
Total Shareholder Return	5.32%	7.32%	7.34%	6.09%	2.33%	1.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.